BIOCRYST PHARMACEUTICALS: Director HEGGIE THERESA buys and sells shares on Aug 13.

Biocryst Pharmaceuticals Inc. [BCRX] recently announced that Director Theresa Heggie has made a series of transactions involving shares of the company's stock. Specifically, on August 13, 2025, she purchased 30,000 shares at a price of $2.91 per share and 40,000 shares at a price of $5.41 per share. Furthermore, she sold 70,000 shares at a price of $8.51 per share on the same day.

BioCryst Pharmaceuticals Inc. [BCRX] recently saw significant share activity involving its director, Theresa Heggie. On August 13, 2025, Heggie made a series of transactions that highlight the volatility and potential for movement in the company's stock. Specifically, she purchased 30,000 shares at $2.91 per share and an additional 40,000 shares at $5.41 per share. Later that day, she sold 70,000 shares at $8.51 per share.

These transactions underscore the recent high levels of implied volatility in BCRX options. According to Nasdaq [1], the Sept. 19, 2025 $4 Call option has exhibited some of the highest implied volatility among equity options today. This suggests that investors are expecting significant movement in BCRX shares, either up or down, possibly due to an upcoming event.

Despite the high implied volatility, analysts are divided on BCRX's fundamental prospects. The company is currently ranked as a Zacks Rank #3 (Hold) in the Medical – Drugs industry, with one analyst increasing and one decreasing their earnings estimates for the current quarter. The net effect has led to a Zacks Consensus Estimate for the current quarter of 3 cents per share [1].

Options traders often look for high implied volatility as an opportunity to sell premium, capturing decay as the options approach expiration. This strategy can be beneficial for traders who believe the underlying stock will not move as much as expected.

BioCryst Pharmaceuticals Inc. [BCRX] is a publicly traded company, and its stock price is subject to market fluctuations based on various factors, including company performance, market conditions, and external events. Investors should conduct thorough research and consider seeking professional advice before making investment decisions.

References:
[1] https://www.nasdaq.com/articles/are-options-traders-betting-big-move-bcrx-stock